Ensure Technologies

EnSure Technologies is an Israeli medical device company specializing in the development of advanced vascular closure devices (VCDs) for interventional cardiology. The company's flagship product, the EnSure VCD, is a mechanical closure system designed to achieve rapid hemostasis in the femoral artery following diagnostic or interventional catheterization procedures. By utilizing a secure mechanical mechanism rather than sutures or pro-thrombotic agents, the technology aims to reduce time-to-hemostasis and allow for earlier patient ambulation. In 2019, the company was acquired by Translumina, a global leader in interventional cardiovascular products, to expand its portfolio of vascular access and structural heart solutions.